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Accurate assessment of kidney function by measurement of glomerular ﬁltration rate (GFR) is essential to the risk assessment
of prospective living kidney donors. We evaluated the performance of various estimating equations for creatinine clearance
(Cockcroft-Gault), GFR (Modiﬁcation of Diet in Renal Disease, Chronic Kidney Disease Epidemiology Collaboration), and
24-hour urine collections for creatinine clearance in obese potential kidney donors. We evaluated 164 potential kidney donors
including 49 with a BMI of 30–35 and 32 with a BMI >35 that have completed a routine living donor evaluation with a measured
GFR. All the estimating equations performed poorly in obese donors. While 24-hour urine collections performed better, only 15%
hadanadequate24-hoururinecollection.Sinceobesekidneydonorsmaybeathigherthanaverageriskforkidneyfailure,accurate
assessment of kidney function in these donors is crucial to ensure their long-term health postdonation.
1.Introduction
Kidney transplantation is considered the treatment of choice
forselectedpatientswithend-stagekidneydisease.Successful
transplantation not only provides a better quality of life but
also survival advantage to these patients [1]. As such, there is
an increasing demand for organs but limited supply. When
compared to deceased donor transplantation, living donor
kidneys provide better long-term patient and graft survival
rates, shorter wait times, as well as an opportunity for early
or preemptive transplant [2]. In addition, transplant surgery
can be performed electively and the graft usually shows
prompt function postoperatively.
Prospective living donors undergo extensive medical
and psychosocial evaluation to ensure that donation is safe
for both recipient and donor. Most transplant programs
have used a glomerular ﬁltration rate (GFR) cut-oﬀ of
80mL/min/1.73m2 to deﬁne optimal live kidney donors [3].
Greater levels of predonation GFR are thought to leave the
living donor with adequate kidney function post-donation.
However, there is no consensus regarding the best method to
determine GFR.
During the last two decades, there has been a dramatic
rise in obesity in the United States with one-third of adults
classiﬁed as obese. Not surprisingly, therefore, the propor-
tion of donors with obesity is also rising, with 19.5% of
living donors having body mass index (BMI) >30kg/m2
in 2008 [4]. Most transplant programs have traditionally
excludedindividualswithaBMI>35kg/m2 fordonationdue
toperceivedhigherriskofperioperativecomplications[3,5].
Increasingly, it is also recognized that obesity mediates risk
in terms of kidney function, either as a direct result of excess
weight or as a consequence of associated comorbidities, such
as diabetes and hypertension [6–9]. Hence, obese donors
should be carefully evaluated and properly educated prior to
kidney donation. In this study, we evaluate the performance
of estimating equations for creatinine clearance and GFR
and assess the accuracy of calculated creatinine clearance by
24-hour urine collection in GFR estimation in normal to
morbidly obese potential kidney donors.
2. Methods
2.1. Study Population. Individuals 18 years and older, who
were evaluated as possible live kidney donors from Septem-
ber 1, 2009 to December 31, 2010 at the University of Illinois
at Chicago were included if they had a measured glomerular
ﬁltration rate (mGFR) completed as part of their workup.2 Journal of Transplantation
The study protocol was approved by the Institutional Review
Board at the University of Illinois at Chicago.
2.2. Estimated Glomerular Filtration Rate and Creatinine
Clearance. Serum creatinine levels were measured during
the initial evaluation of prospective donors. Per institu-
tional protocol, individuals that had a BMI > 30kg/m2
or an inadequate 24-hour urine collection underwent a
measured GFR to assess kidney function. The estimated
glomerular ﬁltration rate (eGFR) was calculated using the
4-variable Modiﬁcation of Diet in Renal Disease study
equation (MDRD) [10] and the Chronic Kidney Disease
Epidemiology Collaboration equation (CKD-EPI) [11].
The creatinine clearance was calculated using a 24-
hour urine collection and estimated by the Cockcroft-Gault
equation based on ideal body weight [12]. All results for
creatinine clearance were corrected for body surface area.
The 24-hour urine collection was determined to be adequate
if the creatinine excretion was between 15–20mg/kg ideal
body weight for women and 20–25mg/kg ideal body weight
for men. Ideal body weight was calculated using the Devine
formula [13]. Serum and urine creatinine values were
measured in the clinical laboratory using the Jaﬀ´ e reaction.
Body surface area was calculated using the Dubois and
Dubois formula [14].
2.3. Measured Glomerular Filtration Rate. Measured GFR
(mGFR) was obtained using Technetium 99m-mercap-
toacetyltriglycine (99mTc-MAG3) renal scan. Brieﬂy, indi-
viduals were given 7mCi of Technetium 99m-mercap-
toacetyltriglycine while in the supine position. Dynamic
images of the kidneys were obtained for 21 minutes and
were read by a radiologist. Absolute GFR was reported and
corrected for body surface area using the Dubois and Dubois
formula [14].
2.4. Statistical Methods. Diﬀerences between continuous
and categorical variables were compared using the one-
way analysis of variance and Chi-square test, respectively.
Continuous variables were reported as mean ± standard
deviation. We evaluated bias that represented the average
diﬀerence between measured and estimated values. A pos-
itive bias indicated that the measured value was higher
than the estimated value. Precision was measured by the
interquartilerange(IQR)ofthediﬀerencebetweenmeasured
and estimated values. Finally, we assessed accuracy by
looking at the percentage of estimated values within 30% of
measured values (P30).
3. Results
3.1. Demographics. During the study period, 164 individuals
completed a 99mTc-MAG3 scan as part of their living donor
evaluation. Of these individuals, 83 had a BMI < 30kg/m2
(Normal group), 49 with a BMI between 30–35kg/m2 (Class
I Obesity group), and 32 with a BMI > 35kg/m2 (Class
II/III Obesity group). The characteristics of each group are
shown in Table 1. Age and ethnicity distribution were similar
among the three groups. There was a lower percentage of
males in the Class II/III Obesity group (16%) compared to
the Normal or Class I Obesity groups (51% for both).
3.2.PerformanceofGFR-EstimatingEquations. Table 2 shows
performance of the three GFR-estimating equations com-
pared to mGFR in the 3 BMI groups. For the Normal
group,theCockcroft-Gaultequationusingidealbodyweight
underestimated mGFR by nearly 20mL/min/1.73m2.T h e
MDRD and CKD-EPI eGFRs were closer to mGFR but the
IQRs were similar for all three equations. The most accurate
was CKD-EPI eGFR for the normal group. The performance
of these equations in Class I Obesity was similar except for a
lower bias for MDRD and CKD-EPI equations.
In the Class II/III Obesity group, the equations did not
p e r f o r ma sw e l l .T h eb i a sf o rM D R Da n dC K D - E P Ie G F R
suggests that the equations overestimate mGFR compared
to the Normal and Class I Obesity groups. The precision
w a sm o r ev a r i a b l eb e t w e e ne q u a t i o n si nt h i sg r o u pa n dt h e
accuracy was lower, especially for the MDRD and CKD-EPI
equations.
3.3. Creatinine Clearance Measurement. All potential kidney
donors also provided a 24-hour collection of urine for
protein excretion and creatinine clearance. In our group
of 164 individuals, 84 (51%) had overcollection, 56 (34%)
had undercollection, and only 24 individuals (15%) had
adequate urine collection by assessing creatinine excretion.
Of these 24, the performance of the 24-hour urine collection
improved for individuals with higher BMI (Table 3). In the
Normal group, only 22% were within 30% of the mGFR as
compared to 75% and 86% in the obese Class I and Class
II/III Obesity groups, respectively.
3.4. Sensitivity and Speciﬁcity. Finally, we evaluated the
sensitivity and speciﬁcity of the three estimating equations
in selecting mGFR of 80mL/min/1.73m2 (Table 4). In the
normal group, the Cockcroft-Gault equation using ideal
body weight had the highest speciﬁcity while the CKD-EPI
had the highest sensitivity. These ﬁndings were similar for
the Class I and Class II/III Obesity groups.
4. Discussion
The primary goal of the extensive medical evaluation for
living kidney donors is to protect the well-being of the
prospective donor. Central to the donor evaluation is the
assessment of predonation kidney function and factors that
may aﬀect it postdonation. Reports of long-term followup
after uninephrectomy suggest that kidney donation is safe
and does not adversely aﬀect the survival or kidney function
of a healthy donor [15–20]. However, eﬀorts to expand
the donor pool have led to changes in the living donor
proﬁles from young, healthy individuals to the inclusion of
older individuals with isolated medical abnormalities such
as hypertension, nephrolithiasis, dyslipidemia, abnormal
glucose tolerance, or obesity [3]. Data available on the long-
term outcomes in such medically complex donors are still
limited.Journal of Transplantation 3
Table 1: Characteristics of potential kidney donors with measured glomerular ﬁltration rate.
Normal (BMI < 30)
(n = 83)
Class I Obesity (BMI 30–35)
(n = 49)
Class II/III Obesity (BMI > 35)
(n = 32) P value
Age (yrs) 39.1 ±12.43 9 .1 ±10.03 5 .7 ±9.70 . 3 0
Weight (kg) 76.5 ±10.79 6 .1 ±10.9 107.6 ±16.3 <0.001
BMI 26.5 ±2.53 2 .3 ±1.44 0 .0 ±4.3 <0.001
Male 42 (51%) 25 (51%) 5 (16%) 0.002
Ethnicity 0.14
White 24 (29%) 9 (18%) 5 (16%)
Black 30 (36%) 21 (43%) 20 (62%)
Hispanic 24 (29%) 13 (27%) 6 (19%)
Other 5 (6%) 6 (12%) 1 (3%)
Abbreviations: BMI—body mass index (kg/m2).
Table 2: Performance of estimating equations.
Bias (mL/min/1.73m2) IQR (mL/min/1.73m2)P 3 0
Normal (BMI < 30) (n = 83)
Cockcroft-Gault CrCl 19.7 ± 2.6 35.3 64%
MDRD eGFR 10.2 ± 2.7 35.6 71%
CKD-EPI eGFR 6.5 ±2.7 35.3 76%
Class I Obesity (BMI 30–35) (n = 49)
Cockcroft-Gault CrCl 17.4 ± 3.6 36.5 61%
MDRD eGFR 0.54 ± 3.9 36.0 69%
CKD-EPI eGFR −3.0 ±3.9 37.9 69%
Class II/III Obesity (BMI > 35) (n = 32)
Cockcroft-Gault CrCl 15.9 ± 3.8 31.9 66%
MDRD eGFR −15.0 ±4.3 37.3 62%
CKD-EPI eGFR −19.2 ±4.1 35.7 56%
Abbreviations: Bias—(measured GF-estimated GFR); IQR—interquartile range; BMI—body mass index (kg/m2); P30—percentage of estimated readings
within 30 percent of measured reading; CrCl—creatinine clearance; MDRD—modiﬁcation of diet in renal disease; CKD-EPI—chronic kidney disease
epidemiology collaboration; eGFR—estimated glomerular ﬁltration rate.
Table 3: Performance of 24-hour creatinine clearance.
Bias
(mL/min/1.73m2)
IQR
(mL/min/1.73m2) P30
Normal
(BMI < 30)
(n = 9)
23.6 ±9.2 38.8 22%
Class I Obesity
(BMI 30–35)
(n = 8)
17.8 ±6.5 23.9 75%
Class II/III
Obesity (BMI >
35) (n = 7)
6.1 ±4.2 10.0 86%
Abbreviations: Bias—(measured GF-estimated GFR); IQR—interquartile
range; BMI—body mass index (kg/m2); P30—percentage of estimated
readings within 30 percent of measured readings.
There is increasing evidence that obese individuals are at
a higher risk of developing kidney disease [6–9]. Even with-
out nephrectomy, obesity is associated with the development
of hypertension and proteinuria. Higher baseline BMI is an
independent predictor for development of kidney failure and
this risk is directly associated with increasing levels of BMI
[21]. Ibrahim et al. also showed that older donor age and
higher BMI were associated with lower GFR and increased
riskofhypertension,eventhoughmostdonorshadpreserved
renal function with rates of hypertension and proteinuria
similar to the general population [16]. In a small study
from Spain, obesity was a risk factor for the development of
proteinuria and kidney failure after unilateral nephrectomy
[22]. Rook et al. also demonstrated that obese individuals
had lower kidney reserve capacity that was unmasked
by donor nephrectomy [23]. Furthermore, Tavakol and
group also found increased incidence of hypertension in
obese donors though it was not associated with long-term
impairments in kidney function in this study [24]. Given the
limited degree of long-term followup in higher risk donors
including obese individuals, it is incumbent on transplant
programs that consider obese donor candidates to accurately
assess kidney function of these donors to avoid future harm
to these individuals.
Measured GFR using urinary or plasma clearance of
exogenous ﬁltration markers is the present gold standard for
the evaluation of donor kidney function [25]. However, due
to the invasive nature and complexity of these techniques,
most transplant programs evaluate their kidney donors by4 Journal of Transplantation
Table 4: Sensitivity and speciﬁcity of estimating equations.
mGFR > 80mL/min/1.73m2
SENS SPEC
Normal
CG-CrCl 51% 67%
MDRD eGFR 74% 47%
CKD-EPI eGFR 81% 40%
Class I Obesity
CG-CrCl 47% 69%
MDRD eGFR 81% 46%
CKD-EPI eGFR 86% 23%
Class II/III Obesity
CG-CrCl 45% 92%
MDRD eGFR 100% 17%
CKD-EPI eGFR 100% 17%
Abbreviations: mGFR—measured glomerular ﬁltration rate; SENS—
sensitivity; SPEC—speciﬁcity; CG-Cockcroft-Gault equation; CrCl—cre-
atinine clearance; MDRD—modiﬁcation of diet in renal disease; CKD-
EPI—chronic kidney disease epidemiology collaboration; eGFR—estimated
glomerular ﬁltration rate.
endogenous creatinine clearance and GFR-estimating equa-
tions. The results of our study show that commonly used
estimating equations for creatinine clearance and GFR per-
form poorly as donor BMI increases. In addition, many
potential donors were unable to complete an adequate 24-
hour urine collection for estimating creatinine clearance.
This is consistent with the ﬁndings of other studies evalu-
ating methods for estimating donor kidney function [26].
We also found that accurate 24-hour urine collection for
creatinine clearance is diﬃcult to obtain and thus, it is
an ineﬃcient method to assess donor GFR. Additionally,
expected creatinine excretion must be calculated according
to ideal body weight, not total body weight, a consideration
particularly important in obese donors.
An interesting ﬁnding in our donor cohort was the
negative bias seen with the MDRD and CKD-EPI equations
in Class II/III obesity indicating an overestimation of GFR
compared to the measured GFR. In healthy individuals, the
MDRD equation is known to underestimate measured GFR
[27, 28], similar to what we found in our normal BMI pop-
ulation. However, the overestimation in Class II/III obesity
has not been reported in healthy individuals. There may be
several possible explanations for this discrepancy between
the measured and estimated GFR. In our cohort, women are
overrepresented in the Class II/III Obesity group. Women
typically have higher body fat content and less muscle mass,
which would lead to lower serum creatinine values and
higher eGFR. Another consideration is the applicability of
estimatingequationsinClassII/IIIObesity,especiallyamong
individuals with presumably normal kidney function. The
MDRD population was mainly composed of individuals
with chronic kidney disease and a mean weight of 79.6 ±
16.8kg which was much lower than our Class I and Class
II/III Obesity groups. The CKD-EPI study included more
individuals with normal kidney function (kidney donors)
and a higher weight and BMI of 82 ± 20kg and 28 ±
6kg/m 2,respectively.WhiletheMDRDandCKD-EPIeGFRs
showed reasonable accuracy and less bias with Class I
Obesity, extrapolation to Class II/III Obesity revealed a
greater diﬀerence between measured and estimated GFRs
and less accuracy.
One limitation of this study is the use of 99mTc-MAG3
scanning. Measured GFR using exogenous ﬁltration markers
(125I-iothalamate, iohexol, diethylenetriaminopenta-acetic
acid) provides potentially greater accuracy of GFR assess-
ment [25]. However, these tests may not be readily available
at most centers. Moreover, additional information obtained
using the 99mTc-MAG3 scanning can be helpful in identi-
fying other aspects of kidney function and blood ﬂow. The
extents to which these parameters are either predictive or
helpful in determining kidney function in the donor (or
recipient) over time are not yet deﬁned in their entirety.
Another limitation is the potential selection bias among
those with 24-hour urine collections. Since individuals with
a normal BMI are more likely to get a measured GFR due
to inadequate 24-hour urine collections, the percentage of
donorswithanadequatecollectionwillbeaﬀected.However,
thepercentageofadequatecollectionsintheClassIandClass
II/IIIObesitygroupstoowasbelow30%,indicatingthistobe
a common problem among all three groups.
Potential concerns for transplant centers are that GFR
measurement using 99mTc-MAG3 (or another type of
radioisotope scan) introduces radiation exposure to the
donor, cost to the evaluation process, and requires personnel
familiar with the testing procedure. However, less invasive
and less expensive methods may not be adequate to accu-
rately measure kidney function in obese donors.
Although the focus of this discussion has been on the
importance of accurate predonation GFR estimation for
the donor, donor GFR estimation is certainly a variable of
importance for the recipient as well. Lower levels of donor
GFR are associated with graft dysfunction and graft loss
[26, 29–31]. More accurate identiﬁcation of donors with
borderline kidney function prior to nephrectomy will at least
inform donor and recipient decision-making regarding the
surgery,aswellaspossiblyidentifyrecipientsatincreasedrisk
for poor outcomes.
5. Conclusions
Accurate determination of GFR is essential to the risk
assessment of prospective kidney donors. Creatinine-based
GFR estimation equations are unreliable for the evaluation
of obese donors. 24-hour urine collection is not only
c u m b e r s o m eb u ta l s of r a u g h tw i t he r r o r sd u et oi n a d e q u a t e
collection in such donors. Further studies are required to
develop better methods of GFR estimation in obese indi-
viduals with normal kidney function. Until then, measured
GFRshouldbeusedasaconﬁrmatorytesttoenhanceclinical
decision making in these circumstances.
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